Vortioxetine (CED0004958)

Record Information
Version1.0
Creation Date2026-04-14 17:37:15 UTC
Update Date2026-08-20 00:48:43 UTC
SynCED IDCED0004958
Secondary Accession Numbers
  • CHEM130319
Identification
Common NameVortioxetine
ClassSmall Molecule
Description
Vortioxetine is an organic compound with the formula C18H22N2S and an average molecular weight of 298.45 g/mol. Vortioxetine belongs to the piperazines, a subclass of diazinanes within the organic compounds. It is classified as an organoheterocyclic compound. This compound is found in or released from one recorded source: healthcare, pharmaceuticals & veterinary products, specifically antidepressants. The recorded route of exposure is oral. Vortioxetine interacts with seven recorded protein targets. It acts as an agonist, antagonist, blocker, inhibitor, ligand, or partial agonist of the sodium-dependent serotonin transporter (SLC6A4), 5-hydroxytryptamine receptor 3A (HTR3A), 5-hydroxytryptamine receptor 7 (HTR7), and 5-hydroxytryptamine receptor 1B (HTR1B), in addition to three other proteins.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC18H22N2S
Average Molecular Mass298.450 g/mol
Monoisotopic Mass298.150 g/mol
CAS Registry Number508233-74-7
IUPAC NameNot Available
Traditional NameNot Available
SMILESCC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1
InChI IdentifierInChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3
InChI KeyYQNWZWMKLDQSAC-UHFFFAOYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted GC-MSPredicted GC-MS Spectrumsplash10-052o-1980000000-f946530f9325fe92b2f1Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
932.0 Log mg/kg [520:1700]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
CEDs000377Antidepressants?Antidepressants, a class of synthetic chemicals designed to alleviate symptoms of depression and anxiety, can enter the environment through various pathways, leading to contamination of water systems.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000518Electrically Stimulated Smoking Devices?Electrically stimulated smoking devices, commonly known as e-cigarettes or vape pens, utilize electrical components to heat a liquid solution, often containing nicotine, flavorings, and other additives, to produce an aerosol for inhalation.Electrical & Electronic EquipmentNot Available
CEDs000559Non Electric Simulated Smoking Devices?Non-electric simulated smoking devices, often designed to mimic the experience of smoking without combustion, can be sources of synthetic chemical contamination due to the materials and chemicals used in their construction and operation.Household cleaning & consumer productsNot Available
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingNot Available
Pathways
2 pathwaysPathway Source: PathBank
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
5-hydroxytryptamine receptor 1A structureClick to view 3D structure5-hydroxytryptamine receptor 1AP08908HumansPredicted (SEA)
Prediction Confidence Score
0.777
Applicability Domain
1.0
Statistical Significance
7.00e-05
Supporting Reference Compounds
953
E-value
0.544945
5-hydroxytryptamine receptor 3A structureClick to view 3D structure5-hydroxytryptamine receptor 3AP46098HumansPredicted (SEA)
Prediction Confidence Score
0.777
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
228
E-value
0.0778492
Click to view 3D structureSodium-dependent serotonin transporterP31652Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.777
Applicability Domain
1.0
Statistical Significance
2.00e-05
Supporting Reference Compounds
297
E-value
0.155698
5-hydroxytryptamine receptor 7 structureClick to view 3D structure5-hydroxytryptamine receptor 7P34969HumansPredicted (SEA)
Prediction Confidence Score
0.622
Applicability Domain
1.0
Statistical Significance
5.00e-04
Supporting Reference Compounds
565
E-value
3.89246
Sodium-dependent serotonin transporter structureClick to view 3D structureSodium-dependent serotonin transporterP31645HumansPredicted (SEA)
Prediction Confidence Score
0.573
Applicability Domain
1.0
Statistical Significance
0.0011
Supporting Reference Compounds
593
E-value
8.25202
Cytochrome P450 2D6 structureClick to view 3D structureCytochrome P450 2D6P10635HumansPredicted (SEA)
Prediction Confidence Score
0.544
Applicability Domain
0.973
Statistical Significance
0.0017
Supporting Reference Compounds
1130
E-value
13.1565
Click to view 3D structureSodium-dependent dopamine transporterP23977Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.533
Applicability Domain
0.973
Statistical Significance
0.001
Supporting Reference Compounds
203
E-value
7.94062
5-hydroxytryptamine receptor 6 structureClick to view 3D structure5-hydroxytryptamine receptor 6P50406HumansPredicted (SEA)
Prediction Confidence Score
0.522
Applicability Domain
0.973
Statistical Significance
0.0014
Supporting Reference Compounds
536
E-value
10.8989
5-hydroxytryptamine receptor 2C structureClick to view 3D structure5-hydroxytryptamine receptor 2CP28335HumansPredicted (SEA)
Prediction Confidence Score
0.503
Applicability Domain
0.973
Statistical Significance
0.0033
Supporting Reference Compounds
823
E-value
25.5345
Beta-1 adrenergic receptor structureClick to view 3D structureBeta-1 adrenergic receptorP08588HumansPredicted (SEA)
Prediction Confidence Score
0.501
Applicability Domain
0.973
Statistical Significance
6.40e-04
Supporting Reference Compounds
180
E-value
4.98235
5-hydroxytryptamine receptor 5A structureClick to view 3D structure5-hydroxytryptamine receptor 5AP47898HumansPredicted (SEA)
Prediction Confidence Score
0.5
Applicability Domain
0.973
Statistical Significance
4.70e-04
Supporting Reference Compounds
225
E-value
3.65891
5-hydroxytryptamine receptor 2A structureClick to view 3D structure5-hydroxytryptamine receptor 2AP28223HumansPredicted (SEA)
Prediction Confidence Score
0.491
Applicability Domain
0.973
Statistical Significance
0.0056
Supporting Reference Compounds
955
E-value
43.5177
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansPredicted (SEA)
Prediction Confidence Score
0.453
Applicability Domain
0.973
Statistical Significance
0.0093
Supporting Reference Compounds
1538
E-value
72.3219
5-hydroxytryptamine receptor 1B structureClick to view 3D structure5-hydroxytryptamine receptor 1BP28222HumansPredicted (SEA)
Prediction Confidence Score
0.446
Applicability Domain
0.973
Statistical Significance
0.0027
Supporting Reference Compounds
337
E-value
21.0193
Histamine H1 receptor structureClick to view 3D structureHistamine H1 receptorP35367HumansPredicted (SEA)
Prediction Confidence Score
0.44
Applicability Domain
0.973
Statistical Significance
0.0048
Supporting Reference Compounds
507
E-value
37.679
Click to view 3D structure5-hydroxytryptamine receptor 1AP19327Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.43
Applicability Domain
0.442
Statistical Significance
0.0094
Supporting Reference Compounds
541
E-value
72.8669
Beta-2 adrenergic receptor structureClick to view 3D structureBeta-2 adrenergic receptorP07550HumansPredicted (SEA)
Prediction Confidence Score
0.424
Applicability Domain
0.973
Statistical Significance
0.0019
Supporting Reference Compounds
258
E-value
14.8692
Click to view 3D structureD(2) dopamine receptorP61169RatPredicted (SEA)
Prediction Confidence Score
0.421
Applicability Domain
0.442
Statistical Significance
0.0116
Supporting Reference Compounds
528
E-value
90.5386
Click to view 3D structure5-hydroxytryptamine receptor 1BP28564Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.421
Applicability Domain
0.442
Statistical Significance
0.0023
Supporting Reference Compounds
154
E-value
17.9053
Click to view 3D structureD(1A) dopamine receptorP18901Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.421
Applicability Domain
0.442
Statistical Significance
0.004
Supporting Reference Compounds
206
E-value
31.1397
Click to view 3D structureAlpha-1A adrenergic receptorP43140Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.38
Applicability Domain
0.52
Statistical Significance
0.0062
Supporting Reference Compounds
208
E-value
48.2665
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)
Prediction Confidence Score
0.377
Applicability Domain
0.432
Statistical Significance
0.0276
Supporting Reference Compounds
1103
E-value
214.942
Histamine H2 receptor structureClick to view 3D structureHistamine H2 receptorP25021HumansPredicted (SEA)
Prediction Confidence Score
0.373
Applicability Domain
0.973
Statistical Significance
0.0047
Supporting Reference Compounds
256
E-value
36.8227
Click to view 3D structure5-hydroxytryptamine receptor 3AP35563Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.364
Applicability Domain
0.973
Statistical Significance
0.0011
Supporting Reference Compounds
36
E-value
8.40772
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)
Prediction Confidence Score
0.339
Applicability Domain
0.409
Statistical Significance
0.031
Supporting Reference Compounds
562
E-value
241.488
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available